Fig. 4

Oncogenic Ras increases the degradation rate of SPSB1. 293 T cells (a, b, c, d) were co-transfected with various SPSB1 and Ras/control construct as indicated. 36 h later, cells were exposed to cycloheximide (20 μg/ml) for indicated periods. Cells in (d) were co-treated with MG132 (25 μM) for indicated periods. Whole cell lysates were then examined for indicated proteins by immunoblotting (IB). Relative intensity of each SPSB1/SPSB1 mutant band (a and c) was qualitatively measured using ImageJ, the number under each band indicated its corresponding relative intensity (Arbitrary Units). The half life ± S.D. (n = 3 technical replicates) for SPSB1/SPSB1 mutant degradation is shown underneath. In all case, each experiment was repeated at least once, one representing result is showing